<?xml-stylesheet type='text/xsl' href='ctgovTransform.xsl'?>
<CT.GOV_Trial requestNumber="534">
  <stage>Registered</stage>
  <submitdate>11/02/2005</submitdate>
  <approvaldate>11/02/2005</approvaldate>
  <nctid>NCT00103636</nctid>
  <trial_identification>
    <studytitle>Peripheral Venous Catheter Trial: 3 Day Versus No Routine Change</studytitle>
    <scientifictitle>Peripheral Venous Catheter Trial: 3 Day Versus No Routine Change</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>RBWH 2003/131</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>Phlebitis</healthcondition>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Other inflammatory or immune system disorders</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Cardiovascular </conditioncode1>
      <conditioncode2>Diseases of the vasculature and circulation including the lymphatic system</conditioncode2>
    </conditioncode>
    <conditioncode>
      <conditioncode1>Blood </conditioncode1>
      <conditioncode2>Clotting disorders</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Treatment: surgery - Extending peripheral intravenous (IV) cannula dwell times

Treatment: surgery: Extending peripheral intravenous (IV) cannula dwell times


</interventions>
    <comparator />
    <control />
    <interventioncode>Treatment: surgery</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Phlebitis during the course of the infusion and up to 48 hours after peripheral venous catheter removal</outcome>
      <timepoint />
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Infiltration permeation of IV fluid into the interstitial compartment</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Local infection at the site of the catheter</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Catheter-related blood stream infection</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Catheter colonization</outcome>
      <timepoint />
    </secondaryOutcome>
    <secondaryOutcome>
      <outcome>Cost</outcome>
      <timepoint />
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Patients are eligible to join the Peripheral Venous Catheter Trial if:

          -  They are inpatients at the Royal Brisbane and Royal Women's Hospital who are at least
             18 years of age

        AND

          -  They are scheduled or expected to have a peripheral venous catheter indwelling for at
             least 4 days.

        AND

          -  They have had their catheter inserted by a nurse from the IV Therapy Team</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage />
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>-  Patients with an existing bloodstream infection

          -  Those receiving immunosuppressive treatment</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 2/Phase 3</phase>
    <anticipatedstartdate />
    <actualstartdate>1/03/2004</actualstartdate>
    <anticipatedenddate />
    <actualenddate />
    <samplesize />
    <actualsamplesize />
    <recruitmentstatus>Unknown status</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate>QLD</recruitmentstate>
    <hospital>Royal Brisbane and Women's Hospital - Brisbane</hospital>
    <postcode>4029 - Brisbane</postcode>
  </recruitment>
  <sponsorship>
    <primarysponsortype>Other</primarysponsortype>
    <primarysponsorname>Royal Brisbane and Women's Hospital</primarysponsorname>
    <primarysponsoraddress />
    <primarysponsorcountry />
  </sponsorship>
  <ethicsAndSummary>
    <summary>The purpose of this study is to investigate the effects of extending the dwell time of
      peripheral intravenous cannulas on clinical outcomes and cost.</summary>
    <trialwebsite>https://clinicaltrials.gov/show/NCT00103636</trialwebsite>
    <publication />
    <ethicsreview />
    <publicnotes />
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Public Queries</type>
    </contact>
  </contacts>
</CT.GOV_Trial>